XML 39 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Beginning balance (in shares) at Dec. 31, 2023 927,904 107,647,317        
Beginning balance at Dec. 31, 2023 $ 9,279 $ 1,076,472 $ 63,853,836 $ (39,418,619)   $ 25,520,968
Net loss       (1,730,404)   (1,730,404)
Share-based compensation     568,588     $ 568,588
Issuance of common stock under equity incentive plan   $ 8,000 (8,000)      
Issuance of common stock under equity incentive plan (in shares)   800,000       800,000
Issuance of common stock for cash, net of issuance costs   $ 23,000 2,736,681     $ 2,759,681
Issuance of common stock for cash, net of issuance costs (in shares)   2,300,000        
Common stock issued upon exercise of warrants   $ 22,040 1,459,800     1,481,840
Common stock issued upon exercise of warrants (in shares)   2,204,000        
Ending balance (in shares) at Dec. 31, 2024 927,904 112,951,317        
Ending balance at Dec. 31, 2024 $ 9,279 $ 1,129,512 68,610,905 (41,149,023)   28,600,673
Net loss       (4,339,526)   (4,339,526)
Share-based compensation     7,081,705     7,081,705
Issuance of common stock under equity incentive plan   $ 23,950 218,395   $ (574,153) $ (331,808)
Issuance of common stock under equity incentive plan (in shares)   2,394,865       2,394,865
Issuance of common stock for cash, net of issuance costs   $ 173,878 104,037,336     $ 104,211,214
Issuance of common stock for cash, net of issuance costs (in shares)   17,387,766        
Common stock issued upon exercise of warrants   $ 73,083 5,659,848     5,732,931
Common stock issued upon exercise of warrants (in shares)   7,308,322        
Ending balance (in shares) at Dec. 31, 2025 927,904 140,042,270        
Ending balance at Dec. 31, 2025 $ 9,279 $ 1,400,423 $ 185,608,189 $ (45,488,549) $ (574,153) $ 140,955,189